Leptospermum Medical Grade Manuka Honey Ointment in the Treatment of Persistent Corneal Epithelial Defect

https://www.tandfonline.com/doi/citedby/10.1080/09273948.2022.2070505?scroll=top&needAccess=true

Waleed K. Alsarhani, Abdullah I. Almater & Majed S. Alkharashi (2022) Leptospermum Medical Grade Manuka Honey Ointment in the Treatment of Persistent Corneal Epithelial Defect, Ocular Immunology and Inflammation, DOI: 10.1080/09273948.2022.2070505

ABSTRACT

Background

To study the efficacy of 100% Leptospermum medical grade Manuka honey ointment in persistent corneal epithelial defects (CEDs).

Methods

Case series.

Results

Case 1 was a 25-year-old female patient who presented to the cornea clinic with a persistent CED (3.5 mm), following acanthamoeba keratitis, that had failed to respond to heavy, frequent lubrication drops and ointment. Two weeks later, after starting Leptospermum honey ointment (4 times per day), the CED healed totally. Case 2 was a 48-year diabatic, single-eyed female patient who presented with a persistent CED (1.5 × 1.5 mm) that had failed to respond to heavy, frequent lubrication drops and ointment. The CED healed three weeks after starting Leptospermum honey ointment (4 times per day).

Conclusions

Leptospermum honey ointment can be a potential treatment for persistent epithelial defect.